AGC Biologics has successfully manufactured more than 200 biological products for pre-clinical studies through commercial approvals. Our global facilities across the United States, Europe and Asia offer multiple cGMP manufacturing lines and a variety of scales for mammalian cell culture and microbial fermentation.
The innovative design of our state-of-the art facilities allows for capacity and technological flexibility, while ensuring compliance with the strict biopharmaceutical regulations required for cGMP operations. Our dedicated and experienced technical teams are committed to helping each client meet their clinical and commercial goals.
Quality matters — to patients, regulatory authorities and our clients. AGC Biologics’ quality organization provides a comprehensive suite of Quality Assurance (QA) and Quality Control (QC) services. Highly trained Quality Units maintain strict quality systems at each of our manufacturing facilities to support our cGMP manufacturing efforts and to ensure compliance with all regulatory requirements.
Our US site is commercially approved by the U.S. Food and Drug Administration (FDA) for commercial cGMP production of two protein therapeutic products. In addition, our Copenhagen facility is approved by FDA, the European Medical Authorities and Health Canada for commercial cGMP manufacture of a protein product. Our facility in Japan has been approved by the Japanese authorities (PMDA) for commercial manufacture of four products for the Japanese market.